Marta Inírida Guerrero

Instituto Nacional de Salud

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Miriam Bobadilla-del-Valle

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

Magali Cavatore

Memorial Sloan Kettering Cancer Center

Lourdes García‐García

Universidade de Santiago de Compostela

Janet Fyfe

Victorian Infectious Diseases Reference Laboratory

José Sifuentes‐Osornio

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

Kathleen D. Eisenach

University of Arkansas for Medical Sciences

Clara Inés León

Centro Dermatológico Federico Lleras Acosta

Manzour Hernando Hazbón

American Type Culture Collection

Alfredo Ponce‐de‐León

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

M. Donald Cave

University of Arkansas for Medical Sciences

Cooperative Institutions

Central Arkansas Veterans Healthcare System

Rutgers New Jersey Medical School

Michigan State University

Rutgers, The State University of New Jersey

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

University of Melbourne

Universidad de Guanajuato

National Institute of Nutrition

Victorian Infectious Diseases Reference Laboratory

Peter Doherty Institute

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy (2006)

Manzour Hernando Hazbón Michael Brimacombe Miriam Bobadilla-del-Valle Magali Cavatore Marta Inírida Guerrero

The molecular basis for isoniazid resistance in Mycobacterium tuberculosis is complex. Putative isoniazid resistance mutations have been identified in katG, ahpC, inhA, kasA, and ndh. However, small sample sizes and related potential biases in sample selection have precluded the development of statistically valid and significant population genetic analyses of clinical isoniazid resistance. We present the first large-scale analysis of 240 alleles previously associated with isoniazid resistance in a diverse set of 608 isoniazid-susceptible and 403 isoniazid-resistant clinical M. tuberculosis isolates. We detected 12 mutant alleles in isoniazid-susceptible isolates, suggesting that these alleles are not involved in isoniazid resistance. However, mutations in katG, ahpC, and inhA were strongly associated with isoniazid resistance, while kasA mutations were associated with isoniazid susceptibility. Remarkably, the distribution of isoniazid resistance-associated mutations was different in isoniazid-monoresistant isolates from that in multidrug-resistant isolates, with significantly fewer isoniazid resistance mutations in the isoniazid-monoresistant group. Mutations in katG315 were significantly more common in the multidrug-resistant isolates. Conversely, mutations in the inhA promoter were significantly more common in isoniazid-monoresistant isolates. We tested for interactions among mutations and resistance to different drugs. Mutations in katG, ahpC, and inhA were associated with rifampin resistance, but only katG315 mutations were associated with ethambutol resistance. There was also a significant inverse association between katG315 mutations and mutations in ahpC or inhA and between mutations in kasA and mutations in ahpC. Our results suggest that isoniazid resistance and the evolution of multidrug-resistant strains are complex dynamic processes that may be influenced by interactions between genes and drug-resistant phenotypes.

INHA

10.1128/aac.00112-06

Cite

Citations (367)

Role of embB Codon 306 Mutations in Mycobacterium tuberculosis Revisited: a Novel Association with Broad Drug Resistance and IS 6110 Clustering Rather than Ethambutol Resistance

Antimicrobial Agents and Chemotherapy (2005)

Manzour Hernando Hazbón Miriam Bobadilla-del-Valle Marta Inírida Guerrero Mandira Varma‐Basil Ingrid Filliol

Mutations at position 306 of embB (embB306) have been proposed as a marker for ethambutol resistance in Mycobacterium tuberculosis; however, recent reports of embB306 mutations in ethambutol-susceptible isolates caused us to question the biological role of this mutation. We tested 1,020 clinical M. tuberculosis isolates with different drug susceptibility patterns and of different geographical origins for associations between embB306 mutations, drug resistance patterns, and major genetic group. One hundred isolates (10%) contained a mutation in embB306; however, only 55 of these mutants were ethambutol resistant. Mutations in embB306 could not be uniquely associated with any particular type of drug resistance and were found in all three major genetic groups. A striking association was observed between these mutations and resistance to any drug (P < 0.001), and the association between embB306 mutations and resistance to increasing numbers of drugs was highly significant (P < 0.001 for trend). We examined the association between embB306 mutations and IS6110 clustering (as a proxy for transmission) among all drug-resistant isolates. Mutations in embB306 were significantly associated with clustering by univariate analysis (odds ratio, 2.44; P = 0.004). In a multivariate model that also included mutations in katG315, katG463, gyrA95, and kasA269, only mutations in embB306 (odds ratio, 2.14; P = 0.008) and katG315 (odds ratio, 1.99; P = 0.015) were found to be independently associated with clustering. In conclusion, embB306 mutations do not cause classical ethambutol resistance but may predispose M. tuberculosis isolates to the development of resistance to increasing numbers of antibiotics and may increase the ability of drug-resistant isolates to be transmitted between subjects.

10.1128/aac.49.9.3794-3802.2005

Cite

Citations (118)

Global Phylogeny of Mycobacterium tuberculosis Based on Single Nucleotide Polymorphism (SNP) Analysis: Insights into Tuberculosis Evolution, Phylogenetic Accuracy of Other DNA Fingerprinting Systems, and Recommendations for a Minimal Standard SNP Set

Journal of Bacteriology (2006)

Ingrid Filliol Alifiya S. Motiwala Magali Cavatore Weihong Qi Manzour Hernando Hazbón

SNP

Mycobacterium tuberculosis complex

10.1128/jb.188.8.3162-3163.2006

Cite

Citations (8)

Global Phylogeny ofMycobacterium tuberculosisBased on Single Nucleotide Polymorphism (SNP) Analysis: Insights into Tuberculosis Evolution, Phylogenetic Accuracy of Other DNA Fingerprinting Systems, and Recommendations for a Minimal Standard SNP Set

Journal of Bacteriology (2005)

Ingrid Filliol Alifiya S. Motiwala Magali Cavatore Weihong Qi Manzour Hernando Hazbón

ABSTRACT We analyzed a global collection of Mycobacterium tuberculosis strains using 212 single nucleotide polymorphism (SNP) markers. SNP nucleotide diversity was high (average across all SNPs, 0.19), and 96% of the SNP locus pairs were in complete linkage disequilibrium. Cluster analyses identified six deeply branching, phylogenetically distinct SNP cluster groups (SCGs) and five subgroups. The SCGs were strongly associated with the geographical origin of the M. tuberculosis samples and the birthplace of the human hosts. The most ancestral cluster (SCG-1) predominated in patients from the Indian subcontinent, while SCG-1 and another ancestral cluster (SCG-2) predominated in patients from East Asia, suggesting that M. tuberculosis first arose in the Indian subcontinent and spread worldwide through East Asia. Restricted SCG diversity and the prevalence of less ancestral SCGs in indigenous populations in Uganda and Mexico suggested a more recent introduction of M. tuberculosis into these regions. The East African Indian and Beijing spoligotypes were concordant with SCG-1 and SCG-2, respectively; X and Central Asian spoligotypes were also associated with one SCG or subgroup combination. Other clades had less consistent associations with SCGs. Mycobacterial interspersed repetitive unit (MIRU) analysis provided less robust phylogenetic information, and only 6 of the 12 MIRU microsatellite loci were highly differentiated between SCGs as measured by G ST . Finally, an algorithm was devised to identify two minimal sets of either 45 or 6 SNPs that could be used in future investigations to enable global collaborations for studies on evolution, strain differentiation, and biological differences of M. tuberculosis .

SNP

Linkage Disequilibrium

10.1128/jb.188.2.759-772.2006

Cite

Citations (429)